Bromocriptine-associated ototoxicity.
Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus suggesting that this drug may produce a reversible ototoxicity.
D000328:Adult; D001299:Audiometry; D001971:Bromocriptine / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged
D001971:Bromocriptine